BRPI0815092A2 - Moduladores duais de receptores 5-ht2a e d3 - Google Patents
Moduladores duais de receptores 5-ht2a e d3Info
- Publication number
- BRPI0815092A2 BRPI0815092A2 BRPI0815092-3A2A BRPI0815092A BRPI0815092A2 BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2 BR PI0815092 A BRPI0815092 A BR PI0815092A BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2
- Authority
- BR
- Brazil
- Prior art keywords
- ht2a
- dual
- receiver modulators
- modulators
- receiver
- Prior art date
Links
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 title 1
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07113252 | 2007-07-26 | ||
| PCT/EP2008/059356 WO2009013212A2 (en) | 2007-07-26 | 2008-07-17 | Dual modulators of 5-ht2a and d3 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0815092A2 true BRPI0815092A2 (pt) | 2015-02-03 |
Family
ID=40281888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0815092-3A2A BRPI0815092A2 (pt) | 2007-07-26 | 2008-07-17 | Moduladores duais de receptores 5-ht2a e d3 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US20090029977A1 (pt) |
| EP (1) | EP2183245B1 (pt) |
| JP (1) | JP5502733B2 (pt) |
| KR (1) | KR101169518B1 (pt) |
| CN (1) | CN101778844B (pt) |
| AR (1) | AR067662A1 (pt) |
| AU (1) | AU2008280187B2 (pt) |
| BR (1) | BRPI0815092A2 (pt) |
| CA (1) | CA2694009A1 (pt) |
| CL (1) | CL2008002162A1 (pt) |
| ES (1) | ES2498673T3 (pt) |
| PE (1) | PE20090892A1 (pt) |
| RU (1) | RU2480466C2 (pt) |
| TW (1) | TWI363623B (pt) |
| WO (1) | WO2009013212A2 (pt) |
| ZA (1) | ZA201000354B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101062513B1 (ko) * | 2006-02-17 | 2011-09-06 | 에프. 호프만-라 로슈 아게 | 5ht2/d3 조절제로서의 벤조일-피페리딘 유도체 |
| CN102159557A (zh) | 2008-09-22 | 2011-08-17 | 弗·哈夫曼-拉罗切有限公司 | 哌嗪d3和5-ht2a受体调节剂 |
| CA2737252A1 (en) | 2008-09-23 | 2010-04-01 | F. Hoffmann-La Roche Ag | Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
| US8470828B2 (en) * | 2010-07-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8877778B2 (en) * | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
| US8722683B2 (en) * | 2011-02-17 | 2014-05-13 | Hoffmann La-Roche Inc. | Benzodioxole piperazine compounds |
| US8598357B2 (en) | 2011-03-03 | 2013-12-03 | Hoffmann-La Roche Inc. | Benzodioxole piperidine compounds |
| US8921397B2 (en) * | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
| CN105367565B (zh) * | 2014-08-20 | 2018-10-02 | 上海医药工业研究院 | 哌嗪(啶)环己基衍生物及其治疗精神神经疾病的应用 |
| WO2017045599A1 (zh) * | 2015-09-15 | 2017-03-23 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| CN106518841B (zh) * | 2015-09-15 | 2019-03-05 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
| US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
| CA3089498A1 (en) | 2018-01-26 | 2019-08-01 | Shionogi & Co., Ltd. | Condensed ring compounds having dopamine d3 receptor antagonistic effect |
| US12617759B2 (en) | 2019-10-29 | 2026-05-05 | Shanghai Hansoh Biomedical Co., Ltd. | Modifier of four-membered ring derivative, preparation method and application thereof |
| KR102947882B1 (ko) * | 2019-11-05 | 2026-04-03 | 상하이 한서 바이오메디컬 컴퍼니 리미티드 | 벤조티오펜 유도체 조절제, 그의 제조 방법 및 그의 용도 |
| BR112022021228A2 (pt) | 2020-04-26 | 2022-12-06 | Jiangsu Nhwa Pharmaceutical Co Ltd | Derivado da 1,5-di-hidro-2,4-benzodiazepin-3-ona e aplicação do mesmo |
| TW202302576A (zh) | 2021-04-28 | 2023-01-16 | 大陸商上海翰森生物醫藥科技有限公司 | 含哌嗪多環類衍生物的鹽及晶型及其製備方法和應用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364866A (en) * | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| DK60693D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| ES2194303T3 (es) | 1997-02-07 | 2003-11-16 | Aventis Pharma Inc | Derivados de (4-piperidinil)-1h-2-benzopirano utiles como agentes antipsicoticos. |
| PT1054885E (pt) * | 1998-02-09 | 2007-10-03 | Duphar Int Res | Derivativos de benzisoxazole tendo uma actividade d4-antagonista |
| DE10010612A1 (de) * | 2000-03-03 | 2001-09-27 | Merck Patent Gmbh | Verwendung von PDE V-Inhibitoren |
| CA2438318A1 (en) | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| ATE455108T1 (de) | 2001-02-16 | 2010-01-15 | Aventis Pharma Inc | Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden |
| GB0117950D0 (en) | 2001-02-16 | 2001-09-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands |
| GB0117577D0 (en) * | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
| KR101062513B1 (ko) * | 2006-02-17 | 2011-09-06 | 에프. 호프만-라 로슈 아게 | 5ht2/d3 조절제로서의 벤조일-피페리딘 유도체 |
| KR101114651B1 (ko) * | 2006-10-31 | 2012-06-12 | 에프. 호프만-라 로슈 아게 | 5-ht2a 및 d3 수용체 이중 조절자 에터 유도체 |
| ES2366766T3 (es) * | 2007-08-09 | 2011-10-25 | F. Hoffmann-La Roche Ag | Derivados de benzoílpiperidina como modulares duales de los receptores 5-ht2a y d3. |
| CN102159557A (zh) * | 2008-09-22 | 2011-08-17 | 弗·哈夫曼-拉罗切有限公司 | 哌嗪d3和5-ht2a受体调节剂 |
| PL2420558T3 (pl) * | 2010-08-17 | 2017-12-29 | The Procter And Gamble Company | Stabilne, trwałe detergenty do ręcznego zmywania naczyń |
| US8877778B2 (en) * | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
-
2008
- 2008-07-17 ES ES08775170.7T patent/ES2498673T3/es active Active
- 2008-07-17 RU RU2010104631/04A patent/RU2480466C2/ru not_active IP Right Cessation
- 2008-07-17 CN CN2008800255361A patent/CN101778844B/zh not_active Expired - Fee Related
- 2008-07-17 WO PCT/EP2008/059356 patent/WO2009013212A2/en not_active Ceased
- 2008-07-17 CA CA2694009A patent/CA2694009A1/en not_active Abandoned
- 2008-07-17 KR KR1020107004201A patent/KR101169518B1/ko not_active Expired - Fee Related
- 2008-07-17 JP JP2010517368A patent/JP5502733B2/ja not_active Expired - Fee Related
- 2008-07-17 EP EP08775170.7A patent/EP2183245B1/en not_active Not-in-force
- 2008-07-17 AU AU2008280187A patent/AU2008280187B2/en not_active Ceased
- 2008-07-17 BR BRPI0815092-3A2A patent/BRPI0815092A2/pt not_active IP Right Cessation
- 2008-07-18 US US12/175,476 patent/US20090029977A1/en not_active Abandoned
- 2008-07-23 PE PE2008001250A patent/PE20090892A1/es not_active Application Discontinuation
- 2008-07-24 AR ARP080103200A patent/AR067662A1/es not_active Application Discontinuation
- 2008-07-24 CL CL2008002162A patent/CL2008002162A1/es unknown
- 2008-07-25 TW TW097128485A patent/TWI363623B/zh not_active IP Right Cessation
-
2010
- 2010-01-18 ZA ZA201000354A patent/ZA201000354B/xx unknown
-
2011
- 2011-10-25 US US13/280,523 patent/US20120040972A1/en not_active Abandoned
-
2013
- 2013-02-21 US US13/772,390 patent/US8829029B2/en not_active Expired - Fee Related
-
2014
- 2014-07-24 US US14/340,093 patent/US20140350051A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008280187B2 (en) | 2013-05-16 |
| EP2183245A2 (en) | 2010-05-12 |
| ZA201000354B (en) | 2010-10-27 |
| CN101778844B (zh) | 2013-01-02 |
| JP2010534632A (ja) | 2010-11-11 |
| PE20090892A1 (es) | 2009-07-13 |
| US20130165432A1 (en) | 2013-06-27 |
| US20120040972A1 (en) | 2012-02-16 |
| TW200911236A (en) | 2009-03-16 |
| AU2008280187A1 (en) | 2009-01-29 |
| US8829029B2 (en) | 2014-09-09 |
| WO2009013212A3 (en) | 2009-06-11 |
| ES2498673T3 (es) | 2014-09-25 |
| RU2010104631A (ru) | 2011-09-10 |
| KR20100036384A (ko) | 2010-04-07 |
| CA2694009A1 (en) | 2009-01-29 |
| JP5502733B2 (ja) | 2014-05-28 |
| EP2183245B1 (en) | 2014-07-09 |
| US20140350051A1 (en) | 2014-11-27 |
| US20090029977A1 (en) | 2009-01-29 |
| CN101778844A (zh) | 2010-07-14 |
| RU2480466C2 (ru) | 2013-04-27 |
| AR067662A1 (es) | 2009-10-21 |
| CL2008002162A1 (es) | 2009-05-29 |
| KR101169518B1 (ko) | 2012-07-27 |
| WO2009013212A2 (en) | 2009-01-29 |
| TWI363623B (en) | 2012-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10930A (es) | Moduladores receptores nicotinicos de acetilcolina | |
| EP2173040A4 (en) | SINGLE PORT SIGNAL BOOSTER | |
| EP2051523A4 (en) | RECEIVER | |
| BRPI0818380A2 (pt) | Combinação de herbicida-protetor | |
| EP2333393A4 (en) | Joint unit | |
| BRPI0903496A2 (pt) | Dispositivos de transmissão e de recepção. | |
| EP2033391A4 (en) | AltBOC RECEIVER | |
| BRPI0921327A2 (pt) | Combinação de herbicida-protetor | |
| GB2452361B (en) | Optical time domain refectometry | |
| BRPI0820978A2 (pt) | Comunicação de conteúdo de alteração visual | |
| EP3270564C0 (en) | DISTRIBUTED SECURITY PROVISION | |
| EP2124523A4 (en) | BREEDING LINE P2428-5006090 | |
| BRPI0918949A2 (pt) | moduladores de receptores de 5-ht2a e piperazina d3 | |
| BRPI0908821A2 (pt) | Transmissão hidrostática com divisão de potência | |
| ATE542825T1 (de) | Substituierte piperidino-dihydrothienopyrimidine | |
| EP2192831A4 (en) | Teat cup lining | |
| ITMI20072422A1 (it) | Ricevitore ottico | |
| EP2153565A4 (en) | TRANSFER MODE SELECTION | |
| EP2116533A4 (en) | Glucokinase AKTIVATOR | |
| BRPI0921058A2 (pt) | éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos | |
| BRPI0811115A2 (pt) | Compostos de heteroarilamida pirimidona | |
| EP2304494A4 (en) | BACKLIGHT UNIT | |
| EP2309690A4 (en) | FSK RECEIVER | |
| BRPI0922728A2 (pt) | combinação de herbicida-antídoto | |
| BRPI0810195A2 (pt) | Moduladores de gpbar1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |